AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,205 | 37,458 | 57,014 | 65,167 | 87,435 |
| Marketable Securities | 146,774 | 144,990 | 136,620 | 54,654 | 27,351 |
| Receivables | 1,254 | 29,429 | 1,275 | 992 | 17,179 |
| Other current assets | 1,248 | 901 | 445 | 305 | 274 |
| TOTAL | $195,368 | $216,760 | $199,626 | $125,596 | $139,408 |
| Non-Current Assets | |||||
| PPE Net | 3,011 | 3,161 | 3,235 | 3,699 | 3,761 |
| Investments And Advances | 471 | 480 | 459 | 474 | 402 |
| Intangibles | 57,268 | 58,256 | 55,745 | 57,631 | 56,158 |
| Other Non-Current Assets | 6,176 | 3,572 | 3,577 | 3,819 | 3,908 |
| TOTAL | $66,926 | $65,468 | $63,016 | $65,623 | $64,229 |
| Total Assets | $262,294 | $282,229 | $262,643 | $191,219 | $203,637 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,019 | 1,636 | 1,587 | 3,243 | 1,870 |
| Accrued Expenses | 13,742 | 14,905 | 13,152 | 12,049 | 12,350 |
| TOTAL | $114,542 | $116,691 | $111,156 | $16,145 | $15,122 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 96,615 | 99,348 | 95,657 | 85 | 154 |
| Other Non-Current Liabilities | 15,045 | 9,598 | 9,299 | 9,689 | 9,574 |
| TOTAL | $20,225 | $15,132 | $15,015 | $9,689 | $9,574 |
| Total Liabilities | $134,767 | $131,823 | $126,171 | $25,834 | $24,696 |
| Shareholders' Equity | |||||
| Common Shares | 2,529 | 2,563 | 2,446 | 2,393 | 2,327 |
| Retained earnings | -418,283 | -403,197 | -392,090 | -380,147 | -352,212 |
| Other shareholders' equity | -253 | -280 | -280 | -160 | -174 |
| TOTAL | $127,528 | $150,406 | $136,471 | $165,385 | $178,940 |
| Total Liabilities And Equity | $262,294 | $282,229 | $262,642 | $191,219 | $203,637 |